CVR number 63141119
Industry 32.5000 Manufacture of medical and dental instruments and supplies

Skomageriet HHS ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  0.9% 1.0% 0.7% 0.7% 0.9%  
Credit score (0-100)  89 86 95 95 87  
Credit rating  A A AA AA A  
Credit limit (kDKK)  253.1 277.0 559.3 413.1 237.5  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Gross profit  7,484 7,681 6,664 5,493 5,253  
EBITDA  500 980 1,300 1,246 874  
EBIT  377 873 1,253 1,160 742  
Pre-tax profit (PTP)  336.0 973.0 1,537.0 1,373.0 823.2  
Net earnings  262.0 759.0 1,200.0 1,070.0 628.7  
Pre-tax profit without non-rec. items  336 973 1,537 1,373 823  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Tangible assets total  288 181 247 378 411  
Shareholders equity total  2,081 2,841 4,040 2,782 1,910  
Interest-bearing liabilities  1,097 68.0 1,352 590 155  
Balance sheet total (assets)  4,978 7,214 8,024 5,607 4,056  
Net Debt  1,041 -729 1,327 556 145  
 
See the entire balance sheet

Volume 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  7,484 7,681 6,664 5,493 5,253  
Gross profit growth  -8.1% 2.6% -13.2% -17.6% -4.4%  
Employees  19 16 10 9 9  
Employee growth %  5.6% -15.8% -37.5% -10.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,978 7,214 8,024 5,607 4,056  
Balance sheet change%  -24.6% 44.9% 11.2% -30.1% -27.7%  
Added value  500.0 980.0 1,300.0 1,207.0 873.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -230 -183 9 34 -109  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  5.0% 11.4% 18.8% 21.1% 14.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  6.7% 16.6% 20.6% 21.4% 17.8%  
ROI %  10.2% 31.8% 36.0% 31.7% 29.7%  
ROE %  13.4% 30.8% 34.9% 31.4% 26.8%  

Solidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  41.8% 39.4% 50.6% 49.9% 47.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  208.2% -74.4% 102.1% 44.6% 16.6%  
Gearing %  52.7% 2.4% 33.5% 21.2% 8.1%  
Net interest  0 0 0 0 0  
Financing costs %  2.9% 6.4% 4.9% 8.9% 9.8%  

Liquidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  1.0 1.4 2.1 2.0 2.0  
Current Ratio  1.7 1.6 2.1 2.0 2.0  
Cash and cash equivalent  56.0 797.0 25.0 34.0 10.5  

Capital use efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,793.0 2,707.0 4,057.0 2,597.0 1,822.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  26 61 130 134 97  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  26 61 130 138 97  
EBIT / employee  20 55 125 129 82  
Net earnings / employee  14 47 120 119 70